Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients
Alimentary Pharmacology & Therapeutics2016Vol. 45(2), pp. 354–363
Citations Over TimeTop 10% of 2016 papers
Monika Widłak, C. Thomas, Mark Thomas, Claudia Tomkins, Steve Smith, Nicola O’Connell, S Wurie, Leonard Burns, Christopher Harmston, Caroline A. Evans, Chuka Nwokolo, Baljit Singh, Ramesh Arasaradnam
Abstract
Undetectable faecal immunochemical test for haemoglobin is sufficiently sensitive to exclude colorectal cancer, with higher values in left-sided lesions. FCP in combination does not appear to provide additional diagnostic information. Further studies to determine the health economic benefits of implementing faecal immunochemical test for haemoglobin in primary care are required.
Related Papers
- → Calprotectin instability may lead to undertreatment in children with IBD(2019)35 cited
- → High negative predictive value of a normal faecal calprotectin in patients with symptomatic intestinal disease(2011)17 cited
- → Faecal calprotectin—a useful screening test for detecting gastrointestinal inflammation in children(2010)
- → Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease – authors’ reply(2016)
- → P06 A single centre description of IBD patients with negative faecal calprotectin at diagnosis(2021)